MedTrace Logo

EMDR Grief Protocol for Traumatic Grief After Earthquake-Related Loss

NCT07776769 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2026-08-20

No results posted yet for this study

Summary

This pilot randomized controlled study evaluated the effectiveness of the EMDR Grief Protocol in adults who experienced the loss of a loved one in the February 6, 2023 Kahramanmaraş earthquakes. A total of 78 adults participated in the study and were randomly assigned to an intervention group or a control group. Participants in the intervention group received three individual sessions of the EMDR Grief Protocol, while the control group received no intervention during the study period. The study evaluated changes in traumatic grief symptoms, post-traumatic stress symptoms, and difficulties in emotional processing before and after the intervention.

Conditions

  • Traumatic Grief
  • Post Traumatic Stress Disorder PTSD
  • Emotional Processing

Interventions

BEHAVIORAL

EMDR Grief Protocol

The EMDR Grief Protocol consisted of three 60-minute individual sessions administered once per week. Session 1 (Past) focused on processing the traumatic moment of death or learning about the death using the standard EMDR protocol based on the Adaptive Information Processing model. Session 2 (Present) focused on current triggers and disruptions in daily functioning. Session 3 (Future) focused on future challenging situations and adaptation to life in the absence of the loved one. All sessions were conducted by a certified EMDR therapist.

Sponsors & Collaborators

  • Istanbul Bilgi University

    lead OTHER

Principal Investigators

  • Şükran Pehlivan Balkır, MSc · Istanbul Bilgi University

  • Ersin Uygun, PhD · Istanbul Bilgi University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-23
Primary Completion
2025-03-19
Completion
2025-03-19

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07776769 on ClinicalTrials.gov